ライフサイエンスコーパス: cyclic adenosine 3',5'-monophosphate

1 on of beta2-adrenergic receptor alters cAMP (cyclic adenosine 3',5'-monophosphate) and triggers PKA (

2 , enabling a comparison of the mechanisms of cyclic adenosine 3',5'-monophosphate biosynthesis.

3 Regulation of intracellular cyclic adenosine 3 ',5 '-monophosphate (cAMP) is integra

4 Cyclic adenosine 3', 5'-monophosphate (cAMP) is a ubiqui

5 An elevation of intracellular cyclic adenosine 3', 5'-monophosphate (cAMP) is known to

6 I-LTD requires cyclic adenosine 3', 5'-monophosphate (cAMP)-dependent p

7 4B (PDE4B) inactivates the second messenger cyclic adenosine 3',5' monophosphate (cAMP) and abrogate

8 of all SCF deletion constructs treated with cyclic adenosine 3',5'-monophosphate (cAMP) and forskoli

9 the hypothesis that increased intracellular cyclic adenosine 3',5'-monophosphate (cAMP) could inhibi

10 Increased cyclic adenosine 3',5'-monophosphate (cAMP) has been pre

11 Experiments were performed with cyclic adenosine 3',5'-monophosphate (cAMP) in the pipet

12 Cyclic adenosine 3',5'-monophosphate (cAMP) is a key sec

13 Cyclic adenosine 3',5'-monophosphate (cAMP) is a recogni

14 iocyte proliferation and secretin-stimulated cyclic adenosine 3',5'-monophosphate (cAMP) levels.

15 secretin receptor (SR) gene expression, and cyclic adenosine 3',5'-monophosphate (cAMP) levels.

16 or (SR) gene expression and secretin-induced cyclic adenosine 3',5'-monophosphate (cAMP) synthesis an

17 ellular development is organized by periodic cyclic adenosine 3',5'-monophosphate (cAMP) waves, which

18 tes generate a pulse of the chemoattractant, cyclic adenosine 3',5'-monophosphate (cAMP), every 6 min

19 PDE3A inhibition generates compartmentalized cyclic adenosine 3',5'-monophosphate (cAMP), which furth

20 Cyclic adenosine 3',5'-monophosphate (cAMP)-elevating ag

21 ical level, CC2D1A transduces signals to the cyclic adenosine 3',5'-monophosphate (cAMP)-protein kina

22 ocess induced by bicarbonate and mediated by cyclic adenosine 3',5'-monophosphate (cAMP).

23 feron-y production in CD8(+) T cells through cyclic adenosine 3',5'-monophosphate (cAMP)/cAMP respons

24 ctivation of parallel fibres (PFs) induces a cyclic adenosine 3'5'-monophosphate (cAMP) and protein k

25 tion in alpha1A-transfected cells, inhibited cyclic adenosine 3'5'-monophosphate (cAMP) formation in

26 PKC agonists induced mkp1 mRNA levels, only cyclic adenosine 3':5'-monophosphate (cAMP)-PKA inhibiti

27 Cyclic adenosine 3, 5-monophosphate (cAMP) levels were m

28 We have examined the cytotoxic effects of cyclic adenosine-3', 5'-monophosphate (cAMP) derivatives

29 ace of intact cells revealed the presence of cyclic adenosine 3':5'-monophosphate-(cAMP) dependent pr

30 Sutherland, who discovered cyclic adenosine 3'-5'-monophosphate (cyclic AMP) and op

31 cting with secretin receptor (SR) activating cyclic adenosine 3',5'-monophosphate/cystic fibrosis tra

32 Similarly, in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein k

33 Agonists that stimulate cyclic adenosine 3',5'-monophosphate production led to a

34 receptor activation to adenylyl cyclase and cyclic adenosine 3'-5' monophosphate production and the

35 tion of A2B receptors recruits the canonical cyclic adenosine 3',5'-monophosphate-protein kinase A si

36 The cyclic adenosine 3',5'-monophosphate receptor protein (C

37 e of protein kinase A (PKA) and dopamine and cyclic adenosine 3',5' monophosphate-regulated phosphopr

38 ian transcription factors-nuclear receptors, cyclic adenosine 3',5'-monophosphate-regulated enhancer

39 in kinase, mitogen-activated protein kinase, cyclic adenosine 3',5'-monophosphate response element bi

40 modulin-dependent protein kinase (CaMK), and cyclic adenosine 3',5'-monophosphate-responsive element-

41 or CaMK kinase in mediating mGluR5-dependent cyclic adenosine 3',5'-monophosphate-responsive element-

42 2+)/calmodulin-dependent protein kinase, and cyclic adenosine 3',5'-monophosphate-responsive element-

43 te after bile duct ligation by activation of cyclic adenosine 3', 5'-monophosphate signaling.

44 The cyclic adenosine 3',5'-monophosphate signalling pathway

45 ts result in the sustained activation of the cyclic adenosine 3',5'-monophosphate system in specific

46 The activated cyclic adenosine 3',5'-monophosphate system leads to the